johns-hopkins
(2)
Neurogazer Turns a 40-Minute Brain Scan Into a Report Card for Who You Might Become
A Johns Hopkins neuroscientist and his CEO brother built a company that reads 169 things out of a single MRI - cognition, temperament, aptitude, risk. From Baltimore, they are betting families will pay to see it.
Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals is a Baltimore-based, clinical-stage drug discovery company spun out of Johns Hopkins University. Its RapaGlue platform designs non-degrading, cell-permeable macrocyclic molecular glues that modulate hard-to-drug intracellular and transmembrane targets - drawing on a proprietary DNA-encoded library of more than 8 billion compounds and machine learning for target selection. The lead program, RAP-0001, is a selective ENT1 inhibitor advancing toward IND-enabling studies for the prevention of acute kidney injury in cardiac surgery patients, with a broader pipeline spanning oncology, immunology, and pain.